RecruitingNot ApplicableNCT04744935

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma


Sponsor

Christopher Zachary

Enrollment

40 participants

Start Date

Jan 13, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Optical coherence tomography guided laser treatment of basal cell carcinoma


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria3

  • Ability to understand and carry out subject instructions or be represented by a legally authorized guardian or representative
  • Ages 18 and older
  • Seeks and is scheduled for treatment of a BCC previously confirmed with biopsy

Exclusion Criteria7

  • Any of the following will exclude participation in the study:
  • Inability to understand and/or carry out instructions
  • Patients with a BCC lesion that requires excision. This would include relatively large lesions (\>2.5 cm diameter), lesions that penetrate deep into the skin beyond the depth of the OCT image capture, high risk lesions as defined by the American Academy of Dermatology as recurrent and sclerosing subtype BCC, or metastases.
  • Patients with periocular BCCs which might expose the patient to risk of damage to eyes from the laser.
  • BCCs on legs due to their tendency towards poor wound healing.
  • Pregnancy
  • Patients unable to follow-up for the full 12 months.

Interventions

DEVICE1064 nm long-pulse Nd:YAG laser

BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.


Locations(1)

UCI Health Gottschalk Medical Plaza

Irvine, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04744935


Related Trials